Skip to content

Replimune Group REPL Finance Lease Liability, Current

Finance Lease Liability, Current at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$52K
Incyte logo
IncyteINCY
$4.41M-1.5%
Moderna logo
ModernaMRNA
$25M+8.7%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$930.59M+28.6%
Enterprise value$885.15M+28.3%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's finance lease liability, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Replimune Group's finance lease liability, current?
Replimune Group (REPL) reported finance lease liability, current of $2.86M in Q4 2025.
How has Replimune Group's finance lease liability, current changed year-over-year?
Replimune Group's finance lease liability, current increased by 3.0% year-over-year, from $2.78M to $2.86M.
What is the long-term trend for Replimune Group's finance lease liability, current?
Over 4 years (2021 to 2025), Replimune Group's finance lease liability, current has grown at a 3.0% compound annual growth rate (CAGR), from $2.49M to $2.8M.
What does finance lease liability, current mean?
Finance lease liabilities (current) represent the portion of lease obligations that are due to be paid within the next twelve months. These obligations arise from long-term contracts where the company effectively controls the leased asset. This metric is critical for assessing near-term liquidity and cash flow requirements.